[1] Chu X,Pan CM,Zhao SX,et al.A genome-wide association study identifies two new risk loci for Graves' disease[J].Nat Genet,2011,43(9):897- 901.
[2] Gu LQ,Zhu W,Zhao SX,et al.Clinical associations of the genetic variants of CTLA-4,Tg,TSHR,PTPN22,PTPN12 and FCRL3 inpatients with Graves' disease[J].Clin Endocrinol(Oxf),2010,72(2):248-255.
[3] Brix TH,Kyvik KO,Christensen K,et al.Evidence for a major role of heredity in Graves'disease:a population-based study of two Danish twin cohorts[J].Clin Endocrinol Metab,2001,86(2):930-934.
[4] 李萍,李永哲.单核苷酸多态性及其分型技术在自身免疫性疾病研究中的应用进展[J].中华检验医学杂志,2010,33(12):1116-1121.
[5] Walunas TL,Lenschow DJ,Bakker CY,et al.Pillars article:CTLA-4 can function as a negative regulator of T cell activation[J].J Immunol,2011,187(7):3466-3474.
[6] Ueda H,Howson JM,Esposito L,et al.Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease[J].Nature,2003,423(6939):506-511.
[7] Jihen B,Mouna S,Fayza A,et al.Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibil-ity to autoimmune type 1 diabetes in Tunisians[J].Clin Vaccine Immunol,2010,17(9):1473-1477.
[8] Khalaf AT,Song JQ,Gao TT,et al.CTLA-4 gene polymorphism and the risk of systemic lupus erythematosus in the Chinese popula-tion[J/OA].J Biomed Biotechnol,2011,2011:167395.
[9] Vaidya B,Oakes EJ,Imrie H,et al.CTLA4 gene and Graves disease:association of Graves disease with the CTLA4 exon 1 and intron 1 polymorphisms,but not with the promoter polymorphism[J].Clin Endocrinol(Oxf),2003,58(6):732-735.
[10] 赵玉芹,刘晓青,刘玮.欧亚人群中CTLA-4+49基因多态性与Graves病遗传易感性关系的Meta分析[J].实用医学杂志,2013,29(19):3241-3244.
[11] Wang PW,Liu RT,Juo SH,et al.Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal[J].J Clin Endocrinol Metab,2004,89(1):169-173.